000 01733 a2200433 4500
005 20250511200339.0
264 0 _c19910610
008 199106s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM199105303242202
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPoynard, T
245 0 0 _aBeta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.
_h[electronic resource]
260 _bThe New England journal of medicine
_cMay 1991
300 _a1532-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Meta-Analysis; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aAscites
_xcomplications
650 0 4 _aEsophageal and Gastric Varices
_xcomplications
650 0 4 _aFemale
650 0 4 _aGastrointestinal Hemorrhage
_xmortality
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xcomplications
650 0 4 _aLiver Cirrhosis, Alcoholic
_xcomplications
650 0 4 _aMale
650 0 4 _aMeta-Analysis as Topic
650 0 4 _aMiddle Aged
650 0 4 _aNadolol
_xtherapeutic use
650 0 4 _aPrognosis
650 0 4 _aPropranolol
_xtherapeutic use
700 1 _aCalès, P
700 1 _aPasta, L
700 1 _aIdeo, G
700 1 _aPascal, J P
700 1 _aPagliaro, L
700 1 _aLebrec, D
773 0 _tThe New England journal of medicine
_gvol. 324
_gno. 22
_gp. 1532-8
856 4 0 _uhttps://doi.org/10.1056/NEJM199105303242202
_zAvailable from publisher's website
999 _c1680518
_d1680518